Trial intelligence / Profile preview

Genotype-tailored nicotine replacement therapy and adherence

2006-000106-24Phase 4Completed

Sponsor
King's College London
Start
Mar 2006
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of nicotine patch in nicotine dependence (2 arms), sponsored by King's College London. Primary endpoint: Adherence to nicotine replacement therapy. Started Mar 2006; status: completed.

02

Drugs

nicotine patch
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on 2006-000106-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000106-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call